§ BIOTECHNOLOGY
USD · BiotechnologyAKRO
AKRO
USDSector · BiotechnologyBeta · 0.14
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
1 increased/new, 0 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 2.59 | EPS (TTM) | -3.74 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| IFP Advisors, Inc | 18 | 0.0% | n/a |
| DekaBank Deutsche Girozentrale | 20K | 0.0% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for AKRO as of the most recent 13F reporting period (Q4 2025 · Period ended Dec 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER100.0% · 0 holders
OTHER0.0% · 2 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AKRO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention AKRO yet.